Andere Kunden interessierten sich auch für
![Design and Synthesis of New Thiazole Derivatives as Anticancer Agents]( "Design and Synthesis of New Thiazole Derivatives as Anticancer Agents")
Design and Synthesis of New Thiazole Derivatives as Anticancer Agents44,99 €![Synthesis of Novel Coupled Nitrogen Heterocyclic Compounds]( "Synthesis of Novel Coupled Nitrogen Heterocyclic Compounds")
Synthesis of Novel Coupled Nitrogen Heterocyclic Compounds29,99 €![Quinazolinone derivatives as anti-microbial agents]( "Quinazolinone derivatives as anti-microbial agents")
Quinazolinone derivatives as anti-microbial agents36,99 €![Design, Synthesis and Evaluation of Some Novel Heterocyclic Compounds]( "Design, Synthesis and Evaluation of Some Novel Heterocyclic Compounds")
Design, Synthesis and Evaluation of Some Novel Heterocyclic Compounds29,99 €![Biological Prospective of Heterocyclic Compounds]( "Biological Prospective of Heterocyclic Compounds")
Biological Prospective of Heterocyclic Compounds36,99 €![Biological Importance of Heterocyclic Compounds in future]( "Biological Importance of Heterocyclic Compounds in future")
Biological Importance of Heterocyclic Compounds in future51,99 €![Standardization and Fingerprinting of Polyherbal Bioactive Compounds]( "Standardization and Fingerprinting of Polyherbal Bioactive Compounds")
Standardization and Fingerprinting of Polyherbal Bioactive Compounds51,99 €
Some new amino substituted quinazoline compounds were synthesized and evaluated for their anticancer activity at National Cancer Institute (NCI), U.S.A. Among the synthesized nine compounds, two were selected for single high dose screening (10-5 M) in full 60 cell panel. Among the selected compounds, 2-benzamido-N-(benzo[d]thiazol-2-yl)benzamide 4 exhibited significant anticancer activity against non-small cell lung cancer NCI-H23, colon cancer HCT-15, CNS cancer SF-539, melanoma SK-MEL-5, ovarian cancer OVCAR-8, renal cancer ACHN, prostate cancer PC-3 and breast cancer MCF7 with inhibition rate of 97.82%, 99.67%, 99.21%, 90.75%, 99.21%, 99.31%, 97.23% and 93.29% respectively. This compound was selected for testing under five dose level screening against 60 cancer cell lines. The results of five dose assay revealed significant anticancer activity of this compound against almost all cancer cell lines.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.